Consistent with the results from the human tumor samples, TMEM16A has been found to be highly expressed in many cell lines with 11q13 amplification, including ZR75–1, HCC1954, and MDA-MB-415 breast cancer cell lines, UM-SCC1, BHY, and Te11 HNSCC cell lines, and FaDu, KYSE30 and KYSE510 ESCC cell lines [42, 44, 50] (Table 1). This evidence concerns the gene ANO1 and head and neck squamous cell carcinoma.